Accès libre

Management of a patient with factor X deficiency with FEIBA: a case report

Luish Borboruah
Luish Borboruah
 et 
Anupam Dutta
Anupam Dutta
   | 09 août 2023
The Journal of Haemophilia Practice's Cover Image
À propos de cet article
Article précédent
Article suivant
Citez
Article Category: Case Study
Publié en ligne: 09 août 2023
Pages: 68 - 73
DOI: https://doi.org/10.2478/jhp-2023-0012
Mots clés
© 2023 Luish Borboruah et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

A report on a case of factor X deficiency from Assam Medical College and Hospital indicates that FEIBA prophylaxis may be a useful therapy in settings where plasma-derived factor X concentrate (pdFX) is not available
A report on a case of factor X deficiency from Assam Medical College and Hospital indicates that FEIBA prophylaxis may be a useful therapy in settings where plasma-derived factor X concentrate (pdFX) is not available

Figure 1:

Genetic analysis Procedure and results of F10 gene testing
Genetic analysis Procedure and results of F10 gene testing

Figure 2.

Timeline overview from first presentation to date
Timeline overview from first presentation to date

Factor assay results

TEST PATIENT VALUE REFERENCE
Factor VIII 173.6% 50-150%
Factor X <1% 50-150%
Fibrinogen 231.5mg/dl 150-450mg/dl
Ristocetin co factor assay 89% 50-175%

Coagulation profile results

TEST PATIENT VALUE REFERENCE
Prothrombin time 52.7s 12.5s
aPTT 84.9s 27.6-42.4s
INR 4.80  
Thrombin time 13.5s 12.0-16.0s
eISSN:
2055-3390
Langue:
Anglais
Périodicité:
Volume Open
Sujets de la revue:
Medicine, Basic Medical Science, other, Clinical Medicine, Pharmacy, Pharmacology
RSS Feed de la revue